These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7936279)

  • 1. Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group.
    Bates D; Ashford E; Dawson R; Ensink FB; Gilhus NE; Olesen J; Pilgrim AJ; Shevlin P
    Neurology; 1994 Sep; 44(9):1587-92. PubMed ID: 7936279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group.
    Gross ML; Kay J; Turner AM; Hallett K; Cleal AL; Hassani H
    Headache; 1994; 34(10):559-63. PubMed ID: 7843948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.
    Cull RE; Price WH; Dunbar A
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):490-5. PubMed ID: 9153607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC
    Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Winner P; Ricalde O; Le Force B; Saper J; Margul B
    Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral blood flow during migraine attacks without aura and effect of sumatriptan.
    Ferrari MD; Haan J; Blokland JA; Arndt JW; Minnee P; Zwinderman AH; Pauwels EK; Saxena PR
    Arch Neurol; 1995 Feb; 52(2):135-9. PubMed ID: 7848120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group.
    Facchinetti F; Bonellie G; Kangasniemi P; Pascual J; Shuaib A
    Obstet Gynecol; 1995 Dec; 86(6):911-6. PubMed ID: 7501338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sumatriptan treatment of migraine in general practice. A randomized, double-blind, placebo-controlled cross-over study].
    Russell MB; Holm-Thomsen OE; Nielsen MR; Cleal A; Pilgrim AJ; Olesen J
    Ugeskr Laeger; 1995 Apr; 157(16):2320-3. PubMed ID: 7652970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan.
    Rapoport AM; Visser WH; Cutler NR; Alderton CJ; Paulsgrove LA; Davis RL; Ferrari MD
    Neurology; 1995 Aug; 45(8):1505-9. PubMed ID: 7644049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.
    Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO
    Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous sumatriptan reduces cilostazol induced headache in migraine patients.
    Falkenberg K; Bjerg HR; Olesen J
    Cephalalgia; 2020 Jul; 40(8):842-850. PubMed ID: 32216457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study.
    Fujita M; Sato K; Nishioka H; Sakai F
    Cephalalgia; 2014 Apr; 34(5):365-75. PubMed ID: 24163282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
    Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E
    Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
    Asadollahi S; Heidari K; Vafaee R; Forouzanfar MM; Amini A; Shahrami A
    Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
    Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.